OMAGNA Canadian Trademark Information
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfuncation, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDS.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment cardiovascular disease central nervous diseases disorders neurological disorders urological disorders urogenital disorders gastrointestinal disorders musculoskeletal disorders allergies diabetes hypertension erectile dysfuncation sexual dysfunction
Abandonment Notice!
On Monday, September 15, 2003,
status on the OMAGNA
trademark changed to Application withdrawn.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Tuesday, February 4, 2003, a canadian trademark registration was filed for
OMAGNA by Agouron Pharmaceuticals, Inc. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1166881.
The current status of this trademark filing is Application withdrawn.
The correspondent listed for
OMAGNA is
GOWLING WLG (CANADA) LLP of *********, **********, ***** ****
The OMAGNA
trademark is filed in the description of
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfuncation, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDS.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information